This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Innovations in Cancer Risk Assessment by Elizabeth Wick
Introduction
Elizabeth Wick is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of cancer research, particularly in understanding the role of biofilms in colorectal cancer risk. With a total of two patents to her name, her work is paving the way for innovative therapies aimed at cancer prevention.
Latest Patents
Wick's latest patents focus on methods for identifying subjects at increased risk of cancer through the detection of biofilms and biofilm-associated microbes. These patents disclose therapies designed to prevent the formation and reduce the size of biofilms in individuals identified as being at elevated risk for colorectal cancer. The inventions provide a framework for identifying subjects at risk based on biofilm detection within the gastrointestinal tract, including biopsy specimens and stool samples. Additionally, the patents discuss therapies involving the administration of antibiotic and probiotic agents to prevent or reduce biofilm formation, potentially in combination with other cancer therapies.
Career Highlights
Elizabeth Wick is affiliated with The Johns Hopkins University, where she conducts her research and develops her innovative ideas. Her work has garnered attention for its potential impact on cancer prevention strategies and patient care.
Collaborations
Wick collaborates with notable colleagues, including Cynthia L Sears and Drew M Pardoll, who contribute to her research efforts and enhance the scope of her work.
Conclusion
Elizabeth Wick's innovative approach to cancer risk assessment through biofilm detection represents a significant advancement in the field. Her patents and research efforts are crucial in developing new therapies aimed at reducing cancer risk and improving patient outcomes.